Complications of topical antimicrobial agents.
Stern
G A
GA
Corneal and External Disease Service, University of Florida College of Medicine, Gainesville 32610.
Killingsworth
D W
DW
D000287:Administration, Topical; D000666:Amphotericin B / Q000009:adverse effects; D000741:Anemia, Aplastic / Q000139:chemically induced; D000890:Anti-Infective Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001550:Benzamidines / Q000009:adverse effects; D002908:Chronic Disease; D003231:Conjunctivitis / Q000139:chemically induced; D003233:Conjunctivitis, Allergic / Q000139:chemically induced; D065306:Corneal Injuries; D003877:Dermatitis, Contact / Q000209:etiology; D003875:Drug Eruptions / Q000209:etiology; D004848:Epithelium / Q000187:drug effects / Q000473:pathology; D006801:Humans; D007065:Idoxuridine / Q000009:adverse effects; D007634:Keratitis / Q000139:chemically induced; D013262:Stevens-Johnson Syndrome / Q000139:chemically induced; D013449:Sulfonamides / Q000009:adverse effects; D014945:Wound Healing / Q000187:drug effects
D000890:Anti-Infective Agents; D001550:Benzamidines; D013449:Sulfonamides; C046651:propamidine isethionate; D000666:Amphotericin B; D007065:Idoxuridine